Impel Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Impel Pharmaceuticals generated cash of -$93,642,000, which is less than the previous year. Cash used in financing activities reached the amount of $67,461,000 last year. Net change in cash is therefore -$27,558,000.
Cash Flow
| 2019 | -36.48M | -1.52M | 21K |
|---|---|---|---|
| 2020 | -39.18M | -1.78M | 11.05M |
| 2021 | -66.36M | -408K | 147.88M |
| 2022 | -93.64M | -1.37M | 67.46M |
IMPL Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 88.21M | 7.09M | 37.00M | 74.99M |
Operating activities | ||||
Net income | -106.31M | -76.53M | -45.79M | -41.85M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 1.20M | 1.08M | 1.07M | 722K |
Stock-based compensation expense | 5.19M | 3.13M | 3.64M | 794K |
| Deferred income tax benefit | 5.19M | 3.13M | 3.64M | 794K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | -6.09M | -1.35M | 0 | 0 |
Inventories | -5.75M | -3.02M | 0 | 0 |
Accounts payable | -275K | 1.99M | 1.49M | 1.42M |
Cash generated by operating activities | -93.64M | -66.36M | -39.18M | -36.48M |
Investing activities | ||||
Purchases Of Investments | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.37M | -408K | -1.78M | -1.52M |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1.37M | -408K | -1.78M | -1.52M |
Financing activities | ||||
Common Stock Issued | 4.25M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -1.1M | 0 |
Cash used in financing activities | 67.46M | 147.88M | 11.05M | 21K |
Net Change In Cash | -27.55M | 81.11M | -29.90M | -37.98M |
Cash at end of period | 60.65M | 88.21M | 7.09M | 37.00M |
| Data source | Data source |